
Please try another search
LTR Pharma Limited, a biopharmaceutical company, engages in the research and development of intranasal spray for the treatment erectile dysfunction (ED) in Australia. Its lead product candidate is SPONTAN, an intranasal delivery technology, an oral PDE5 inhibitor and vardenafil HCL for the treatment of ED. The company was incorporated in 2020 and is headquartered in Brisbane, Australia.
Name | Age | Since | Title |
---|---|---|---|
Lee Rodne | - | 2020 | Executive Chairman |
Julian John Chick | 56 | 2020 | Independent Non-Executive Director |
Russ Chess-Williams | - | - | Member of the Scientific Advisory Board |
Eric Chung | - | - | Member of the Scientific Advisory Board |
Maja Aleksandra McGuire | - | 2021 | Independent Non-Executive Director |
Jay Rodne | - | - | Director of LTR Inc. |
Darren Katz | - | 2025 | Member of the Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review